Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Surf;
Today's SOMX PPS is $0.30 pre split. It seems not valuing itself so highly. Law suits showed up right away. Letssee whatshareholders will say.
GL
mlkr
7:01AM Somaxon Pharma to be acquired by Pernix Therapeutics (PTX); Somaxon shareholders to receive $25 mln in Pernix Common Stock (SOMX) 1.47 : Under the terms of the agreement, which has been unanimously approved by the boards of directors of both companies, Somaxon stockholders will receive aggregate consideration equal to $25 mln in Pernix common stock. The number of shares of Pernix common stock to be issued to the stockholders of Somaxon will be based on the volume-weighted average price of Pernix's common stock over the 30 day period ending on the day immediately prior to the closing of the proposed merger, subject to limitations on the maximum and minimum number of shares of Pernix common stock issuable in the transaction based on a price range of $6.00 to $9.00 per share.
8:05AM Somaxon Pharmaceuticals approves 1-for-8 reverse stock split and decrease in the number of authorized shares of its common stock to 25 mln shares (SOMX) 0.26 : Co announced that its Board of Directors approved a 1-for-8 reverse stock split of its common stock and a decrease in the number of authorized shares of its common stock from 100,000,000 to 25,000,000 shares. The reverse stock split and the decrease in the number of authorized shares of common stock were authorized by Somaxon's stockholders at a special meeting held on October 5, 2012.
Now it is $0.26
On watch list for tax loss selling into Dec & then maybe a nice bounce in Jan(possible buy in Dec)
don't hold your breath, chart shows otherwise.
Does it anyone know why with such huge volume the price is barely budging since hitting high this morning? Looks like all the action is happening within .33's range.
Would this volume surge precede price movement soon?
Thinking of getting position here.
THERE SHE GOES! SOMX
looks like we might be in for a reversal SOMX
Where you get the news that never arrive or are a sham, if not give the exact source of that information?
Could you give an explanation for the forecast of SOMX to $ 1, refers to how long?.
or otherwise is an evil basher who wants people to buy you out
you really, are noy a good guru...jajajajaj
Stox sale @ $0.32
Somaxon Pharma enters aggreement to sell 9.4 mln shares of common stock and warrants at $0.32 (SOMX) 0.42 : Co annouces a definitive agreements to sell approximately 9.4 mln shares of its common stock and warrants to purchase up to approximately 4.7 mln shares of its common stock to institutional investors at a combined public offering price of $0.32 per share and per warrant for aggregate gross proceeds of ~$3.0 mln. The warrants will have an initial exercise price of $0.46 per share
Looking at the chart this could correct down to the .20's
http://stockcharts.com/h-sc/ui?s=SOMX&p=D&yr=0&mn=4&dy=0&id=p44679267776
Here is your news but looks more like .32 coming sooner.
http://www.globenewswire.com/newsroom/news.html?d=262870
Well I guess I can scratch this board for any valuable insight of D&D or chart analysis....oh wait...jboogie is here!!...and he said news is comming!!....hold on tight fellas...to the mooooon!!!! ....sheesh....i degress
I heard the insiders or insider who sold was getting replaced so he bailed lol..but the pps. Still went up he sold for a way lower price at what the stock is trading now
The early bird catches the worm..great amazing news in the way
SOMX Looks cooked and done for now can't sustain any gains it seems last couple of days
Nice, up 60% so far.
That gap was a sell this morning.....
definitely a possibility. exclusive patent secured to 2020; JVs in place with PLB and PG; approval pathway into the Canadian market; highly marketable product. Only problem is, buy outs are a blue moon phenomenon for any small cap and any biotech product. Either way, it's all looking up for SOMX, for the next while.
Poster on yahoo finance suggested this opens up buy out talks?
Thoughts?
I agree, I was going to jump in and 1st think I check our insiders buying or selling, because news like this is pretty dam good! But for an insider to dump 2mil shares something smells. Better to hold off and see how it trades tomorrow. If it's going to run we can still chase it a little and get in and out make our $.
Yeah, after seeing this I don't want to hold overnight. Very strange. I sold my shares @ $0.55c
Doesn't make sense to me either. I'm starting to think this doesn't do too well tomorrow...
Float dont matter, What I want to know is why most senior guys in the company all sold out 2 weeks before this news hit.. That is the strange part.
Can you explain that to me a little better. I dont understand.
Just smart traders working with the MM's to get out from under their losses.
Meaning this time last year this stock was trading over $1 and the bag holders had a chance on the news to get out.
http://stockcharts.com/h-sc/ui?s=SOMX&p=D&yr=1&mn=0&dy=0&id=p97249221984
Extended Hours 0.55
Last Trade 0.29 (+111.54%)
After Hours Change
826,299
Volume 6:42:09 PM EDT
Good volume but I still dont understand why insiders sold 2 weeks ago for .30...Anyhow I dont pay to much attention to AH right now. Lets see how it does in the AM.
.56 x .57
my 10K @ .65c isn't looking good
Somaxon Pharma Announces Settlement of Silenor Patent Litigation With Mylan (MYL) and PAR (PRX) (SOMX) 0.26 -0.01 : Co announced that it has entered into separate settlement arrangements with Mylan Inc. (MYL) and its subsidiary, Mylan Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. and its subsidiary Par Pharmaceutical, Inc. (PRX) to resolve pending patent litigation involving Silenor 3 mg and 6 mg tablets. The settlement agreement with Mylan grants Mylan the exclusive right to begin selling an authorized generic version of Silenor on January 1, 2020, or earlier under certain circumstances. Mylan's right to sell such an authorized generic product could extend for a period of as long as 360 days, and after such period Mylan will have the non-exclusive right to sell a generic version of Silenor under its Abbreviated New Drug Application. In connection with the settlement agreement, the parties also entered into a supply agreement under which Mylan has agreed to supply the company with commercial quantities of Silenor 3 mg and 6 mg tablets. The settlement agreement with Par grants Par the right to begin selling a generic version of Silenor 180 days after the earlier of the date that a third party's generic version of Silenor is first sold in the United States under a license from Somaxon or a final court decision that the asserted patents are not infringed, invalid or unenforceable, or earlier under certain circumstances. Each of the settlement agreements will become effective upon the entry by the U.S. District Court for the District of Delaware of an order dismissing the litigation with respect to Mylan or Par, as applicable.
Wow huge news but yet so strange why a ton of insiders sold?
Insider Position Date Trades Shares Trade Price ($) Change (%) Details
EVNIN LUKE 10% Owner 2012-07-09 Sell 2,295,791 $0.3 -13.33 view
MPM BIOVENTURES III-QP L.P. 10% Owner 2012-07-09 Sell 2,295,791 $0.3 -13.33 view
EVNIN LUKE 10% Owner 2012-07-03 Sell 178,558 $0.29 -10.34 view
MPM BIOVENTURES III-QP L.P. 10% Owner 2012-07-02 Sell 178,558 $0.29 -10.34 view
MPM BIOVENTURES III-QP L.P. 10% Owner 2012-06-28 Sell 19,500 $0.29 -10.34 view
EVNIN LUKE 10% Owner 2012-06-28 Sell 19,500 $0.29 -10.34 view
EVNIN LUKE 10% Owner 2012-06-19 Sell 12,000 $0.29 -10.34 view
MPM BIOVENTURES III-QP L.P. 10% Owner 2012-06-19 Sell 12,000 $0.29 -10.34 view
EVNIN LUKE 10% Owner 2012-06-15 Sell 1,450 $0.29 -10.34 view
MPM BIOVENTURES III-QP L.P. 10% Owner 2012-06-15 Sell 1,450 $0.29 -10.34 view
hey! . . . SOMX just showed up on my Monthly Seasonal Scan of August.
Seeing as the Market has Dropped in July so far, I figured it would be
a good time to Buy some August Seasonals (stocks that go Up most every August).
You can see SOMX Stock Seasonality for free at that link.
I am a member so I can do scans and get more detailed information.
BUT . . I searched for a board on SOMX here and found you guys!
What do you all think about this penny stock ??
How does it look for going Up from here ??
Any bad news about it out recently ??
I have read the Financial News, but wanted the dirt from you guys who have been following it more closely.
Let me know . . . thanks !!!!
Little bit of news and this stock could move nicely, imo. STO is starting to trend up the past few days, and accumulation has been steady. I got in at 27 here a couple of days ago--imo, next week could be decent!
SOMX Chart Analysis – Stuck in a long term downtrend, starting to see some short term strength though
http://ichartpennystocks.com/somx-chart-analysis-stuck-in-a-long-term-downtrend-starting-to-see-some-short-term-strength-though/
Nice close TODAY! I expect new attack to MA(20) at $0.49!
IMHO.
Nice point in SOMX. Time to buy.
IMHO.
Somaxon and CJ CheilJedang Announce Silenor® Collaboration in South Korea
Business WirePress Release: Somaxon Pharmaceuticals, Inc. – Fri, Apr 27, 2012 8:00 AM EDT
Somaxon and CJ CheilJedang Announce Silenor® Collaboration in South KoreaView Photo
Somaxon and CJ CheilJedang Announce Silenor® Collaboration in South Korea
SAN DIEGO & SEOUL, South Korea--(BUSINESS WIRE)--
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX - News) and CJ CheilJedang Corporation today announced that they have entered into an exclusive collaboration under which CJ CheilJedang will commercialize Silenor® (doxepin) for the treatment of insomnia in South Korea.
Under the terms of the agreements, Somaxon will receive an up-front payment of US$600,000. CJ CheilJedang will be responsible for regulatory submissions for Silenor and will have the exclusive right to commercialize Silenor in South Korea. Once Silenor is approved in South Korea, Somaxon will also be eligible to receive sales-based milestone payments as well as a royalty based on net sales of Silenor in South Korea. Somaxon will also supply CJ CheilJedang’s requirements for commercial quantities of Silenor in South Korea at a separate transfer price.
“This transaction helps us further our goal of maximizing the value of Silenor for our stockholders by selectively licensing rights to the product outside of the U.S.,” said Richard W. Pascoe, Somaxon’s President and Chief Executive Officer. “CJ CheilJedang is a leading pharmaceutical company in South Korea with an impressive track record of achieving regulatory approval and effectively commercializing branded pharmaceutical products.”
“We are pleased to partner with Somaxon to commercialize Silenor in South Korea,” said Seok-Hee Kang, Head of Pharmaceutical Business of CJ CheilJedang Corporation. “Silenor is an excellent fit with CJ CheilJedang's commercial capabilities and portfolio, and we believe that there is a significant unmet need for Silenor.”
About Silenor®
Silenor is a low-dose (3 mg and 6 mg) oral tablet formulation of doxepin, and is the first and only non-scheduled prescription sleep medication approved to treat insomnia characterized by difficulties with sleep maintenance. Sleep maintenance is defined as waking frequently during the night and/or waking too early and being unable to return to sleep. For more information, please visit www.silenor.com.
looks like the entry point to me?
18:05 EDT SOMX April 2nd
theflyonthewall.com: Somaxon to seek other third party pacts, Bloomberg says
Subscribe for More Information :theflyonthewall.com
18:04 EDT PG, SOMX
theflyonthewall.com: Somaxon: P&G no longer has rights to OTC product in pact, Bloomberg says
Subscribe for More Information :theflyonthewall.com
18:02 EDT PG, SOMX
theflyonthewall.com: Somaxon: P&G didn't negotiate to develop OTC Doxepin product, Bloomberg says
Followers
|
28
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
854
|
Created
|
08/09/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |